Thrombin generation and fibrin clot structure after vitamin D supplementation

Abstract

Objective: Vitamin D deficiency is associated with increased risks of arte rial and venous cardiovascular events. Hypothetically, supplementation with vitamin D may lead to a less prothrombotic phenotype, as measured by global coagulation assa ys and fibrin clot structure. Methods: In this prospective cohort study, we enrolled adult outpatient s attending the Primary Care Division of the Geneva University Hospitals wi th a severe vitamin D deficiency (25-hydroxyvitamin-D3 (25-OHD) <25 nmol/L), excluding obese patients or with a recent acute medical event. We evaluated changes in coag ulation times, thrombin generation assay, clot formation and clot lysis time, 25-OHD an d parathormone before and 1–3 months after cholecalciferol oral supplementation with one-time 300,000 IU then 800 IU daily. Paired t-tests with a two-sided alpha of 0.05 compared absolute mean differences. Results: The 48 participants had a mean age of 43.8 ± 13.8 years. After supplementation, 25-OHD levels increased from 17.9 ± 4.6 nmol/L to 62.5 ± 20.7 nmol/L 6.4 ± 3.0 weeks after inclusion. Endogenous thrombin potential and thrombin generation peak values both decreased significantly (−95.4 nM × min (95%CI −127.9 to −62.8), P < 0.001; −15.1 nM (−23.3 to −6.8), P < 0.001). The maximum absorbance by turbidimetry decreased significantly (P = 0.001) after supplementation. There was no change in clot lysis time, coagulation times or plasminogen activator inhibitor-1 and homocysteine levels. Conclusions: In severe vitamin D deficiency, a high-dose cholecalciferol sup plementation was associated with a reduction in thrombin generation and an a verage decreased number of fibrin protofibrils per fibers and fibrin fiber size measu red by turbidimetry. This suggests that severe vitamin D deficiency may be associated with a potentially reversible prothrombotic profile.

Keywords

• vitamin d
• parathyroid hormone
• cardiovascular
• hormone action